|
Immune-related adverse event (irAE) education, self-efficacy, and potential irAE experiences in patients treated with immunotherapy for non-small cell lung cancer (NSCLC). |
|
|
Employment - Cardinal Health; PatientsLikeMe |
Stock and Other Ownership Interests - Cardinal Health; PatientsLikeMe |
|
|
Employment - AstraZeneca; AstraZeneca (I) |
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I) |
|
|
Employment - PatientsLikeMe |
Stock and Other Ownership Interests - PatientsLikeMe |
|
|
No Relationships to Disclose |
|
|
Employment - PatientsLikeMe |
Stock and Other Ownership Interests - PatientsLikeMe |
|
|
|
|
|
|
|
|
|
Stock and Other Ownership Interests - AstraZeneca; AstraZeneca (I) |